Autopsy report · NCT02321384
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RO6889678 and the Combination of RO6889678 With Ritonavir in Healthy Participants
Cause of deathNo reason given
Life of this trial
- Ran for about 11 months before it stopped.
- 100 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Hoffmann-La Roche
- Sponsor type
- Industry
- Conditions
- Healthy Volunteer
- Interventions
- Placebo; RO6889678; Midazolam; Ritonavir
- Participants
- 100
- Sites
- 1
- Countries
- Netherlands
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.